EIKON
DEAD

Serial Number

90690440

Owner

EIKON THERAPEUTICS, INC.

Attorney

Ilene B. Tannen

Filing Date

May 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

EIKON Trademark

Serial Number: 90690440

EIKON is a trademark filed by EIKON THERAPEUTICS, INC. on May 4, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

EIKON THERAPEUTICS, INC.

230 Harriet Tubman Way
Millbrae, CA 94030

Entity Type: 03

Trademark Details

Filing Date

May 4, 2021

Registration Date

Not Registered

Published for Opposition

August 2, 2022

Goods & Services

Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 31, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 31, 2025 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 25, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 25, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 25, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2025 EXRA
SOU EXTENSION 5 GRANTED
Mar 26, 2025 EX5G
SOU EXTENSION 5 FILED
Jan 30, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 5, 2024 EXRA
SOU EXTENSION 4 GRANTED
Sep 5, 2024 EX4G
SOU EXTENSION 4 FILED
Sep 5, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 5, 2024 EXRA
SOU EXTENSION 3 GRANTED
Mar 4, 2024 EX3G
SOU EXTENSION 3 FILED
Mar 4, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 4, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 26, 2023 EXRA
SOU EXTENSION 2 GRANTED
Sep 22, 2023 EX2G
SOU EXTENSION 2 FILED
Sep 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 22, 2023 EXRA
SOU EXTENSION 1 GRANTED
Mar 20, 2023 EX1G
SOU EXTENSION 1 FILED
Mar 20, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 20, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 27, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 25, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 25, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 25, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 25, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 6, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 13, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 13, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 13, 2021 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2021 NWOS
NEW APPLICATION ENTERED
May 7, 2021 NWAP